Cargando…
Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension
Autores principales: | Perez-Vizcaino, Francisco, Mondejar-Parreño, Gema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440269/ https://www.ncbi.nlm.nih.gov/pubmed/36090757 http://dx.doi.org/10.1016/j.omtn.2022.08.015 |
Ejemplares similares
-
Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021) -
Kv7 Channels in Lung Diseases
por: Mondejar-Parreño, Gema, et al.
Publicado: (2020) -
Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
por: Callejo, María, et al.
Publicado: (2018) -
Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021) -
Association between miR-212-3p and SOX11, and the effects of miR-212-3p on cell proliferation and migration in mantle cell lymphoma
por: Tian, Yuyang, et al.
Publicado: (2021)